Lithium may help prevent the progression of tau neuropathology in AD by inhibiting GSK-3β and modifying the expression or activity of other tau kinases, such as protein kinase A (PKA), Akt (PKB), and calcium/calmodulin-dependent kinase II (CaMKII) [60,66,75]. Here, MAPT is linked to Alzheimer disease.